VITA PHARMA LIMITED

Pioneering advanced treatments to address significant unmet medical needs in chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease.

General Information
Company Name
VITA PHARMA LIMITED
Founded Year
2001
Location (Offices)
+1
Founders / Decision Makers
Charles Newhall - Director and Member of Audit Committee
Number of Employees
2
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series Unknown
Social Media

VITA PHARMA LIMITED - Company Profile

VITA PHARMA LIMITED, founded in 2001, is a clinical-stage biopharmaceutical company with the slogan "Pioneering advanced treatments to address significant unmet medical needs in chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease." The company is dedicated to developing a portfolio of innovative, small molecule, top-tier compounds that target expansive markets with significant unmet medical needs. Its focus lies on conditions such as chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease within the industries of Biotechnology, Health Care, and Pharmaceutical. The company secured a notable $15.00M Venture Round investment on 09 June 2009. This puts the company in a strong position to advance its clinical-stage developments and work towards addressing critical medical needs in various disease areas. Although information about the specific investors or the headquarters is not available, the recent investment demonstrates ongoing interest and confidence in the company's potential for growth and success within the biopharmaceutical industry.

Taxonomy: biopharmaceutical company, clinical-stage, chronic kidney disease, diabetes, atherosclerosis, Alzheimer's disease, innovative treatments, small molecule compounds, significant unmet medical needs, top-tier compounds, expansive markets, novel compounds, best-in-class compounds

Funding Rounds & Investors of VITA PHARMA LIMITED (5)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $15.00M - 09 Jun 2009
Series D $15.00M 4
New Enterprise Associates, investor in VITA PHARMA LIMITED's Series D round Atlas Venture, investor in VITA PHARMA LIMITED's Series D round Prospect Venture Partners, investor in VITA PHARMA LIMITED's Series D round Venrock, investor in VITA PHARMA LIMITED's Series D round
06 Nov 2007
Series C $15.00M 5
New Enterprise Associates, investor in VITA PHARMA LIMITED's Series C round Atlas Venture, investor in VITA PHARMA LIMITED's Series C round Prospect Venture Partners, investor in VITA PHARMA LIMITED's Series C round Venrock, investor in VITA PHARMA LIMITED's Series C round Wellcome Trust, investor in VITA PHARMA LIMITED's Series C round
14 Jul 2005
Series B $34.00M 1
Venrock, investor in VITA PHARMA LIMITED's Series B round
04 Jan 2005
Series B $15.00M - 14 Jan 2004

Latest News of VITA PHARMA LIMITED

View All

No recent news or press coverage available for VITA PHARMA LIMITED.

Similar Companies to VITA PHARMA LIMITED

View All
ONCOCROSS Co., Ltd. - Similar company to VITA PHARMA LIMITED
ONCOCROSS Co., Ltd. AI, drug discovery development, biotechnology, indication expansion, rare disease, intractable disease, oncology, CUP
Tagomics - Similar company to VITA PHARMA LIMITED
Tagomics Decoding disease using multiomics
ROBOSCIENTIFIC LIMITED - Similar company to VITA PHARMA LIMITED
ROBOSCIENTIFIC LIMITED VOC Sensing on-farm detecting disease in livestock and crops. VOC Analysers for use in labs or in the field
Molecules For Health Inc - Similar company to VITA PHARMA LIMITED
Molecules For Health Inc Creating breakthrough therapies with Didox to combat sickle cell disease and breast cancer, backed by exceptional antitumor activity in clinical trials.
CardiaTec Bio - Similar company to VITA PHARMA LIMITED
CardiaTec Bio Decoding cardiovascular disease biology for novel therapeutic discovery